By distributing this form, you affirm that UCB has your permission to use your own details to provide you with information and gives associated with UCB on goods, solutions and systems, and opportunities to be involved in market place study.Influence of coadministration of a twin CYP3A4 and CYP2C19 inhibitor with fedratinib has not been analyzed.en